EQUITY ALERT: Lawsuit Filed Against Sanofi to Recover Investor Losses - SNY

NEW YORK, Dec. 5, 2014 (GLOBE NEWSWIRE) -- The Rosen Law Firm, a global investor-rights firm, announces that a class action lawsuit has been filed on behalf of purchasers of Sanofi securities SNY during the period from February 7, 2013 through December 3, 2014.

To join the Sanofi class action, go to the website http://www.rosenlegal.com/cases-455.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or kchan@rosenlegal.com for information on the class action.

"Disregarding truthful disclosure and fueled by corporate greed, the lawsuit claims that Sanofi engaged in an illegal scheme to funnel tens of millions of dollars in kickbacks and other incentives to get the Company's diabetes drugs prescribed and sold," said Rosen attorney Phillip Kim. As a result, the lawsuit claims that the Company's public statements were materially false and misleading at all relevant times. "This looks to be another instance of a large company attempting to profit from its misdeeds at the expense of their investors," added Kim.

NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.

A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than February 2, 2015. If you wish to join the class action go to http://www.rosenlegal.com/cases-455.html or to discuss your rights or interests regarding this class action, please contact, Phillip Kim, Esq. or Kevin Chan, Esq. of The Rosen Law Firm toll free at 866-767-3653 or via e-mail at pkim@rosenlegal.com or kchan@rosenlegal.com.

The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.